Company Profile
Sichuan Ziren Pharmaceuticals Co., Ltd is located in 3rd. West Shenzhen Road, Guanghan Economic & Technical Development Zone, Sichuan, China. Has the honor to receive “National High-tech Enterprise” title in 2014.Ziren has been adhering to the “The strength casts the achievement of future” spirit, “Promote the human health, Enhance the quality of public life, Achieve the maximum development of social returns and all employees' personal development” business philosophy, effort to build domestic and international specialized production bases of digestive tract medicine, developing into Proprietary Chinese medicine, APIs, Biologics, chemical drugs national well-known enterprises. Ziren has solid research team, advanced develop concept, rich technical experiences and strong technical strength. While developing its own R & D capabilities, Ziren is actively engaged in cooperate with colleges and research institutes, to make the results of science and technology for the benefit of human health. Ziren forming the strategic cooperative coalition with 302 People's Liberation Army Hospital, Zhejiang University of Technology and Sichuan University, collaborate on developing technologies and products. Ziren currently have 7 utility model patents, has declared 1 national invention patent and 1 design patent. Ziren has been appraised as "observe contracts and keep promises" enterprise for four years. In 2014, Ziren invested 10,000,000 yuan built the APIs aseptic workshop, which successfully passed GMP authentication, being the first enterprise to pass the certificate in Sichuan Province.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
100% Andrographis Paniculata Extract Andrographolides |
2(3H)-Furanone,3-[2-[(1R,4aS,5R,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-,(3E,4S)-;5β,9βH,10α-Labda-8(20),12-dien-16-oic acid,3α,14,15,18-tetrahydroxy-,γ-lactone;2(3H)-Furanone,3-[2-[decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-,[1R-[1α[E(S*)],4aβ,5α,6α,8aα]]-;Andrographis;(3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-2(3H)-furanone;Andrographolide;Andrographolid;3-dehydroandrographolide or 19-dehydroandrographolide? p. 1388;Andrographiside aglycon;101060-34-8;5953-53-7 |
5508-58-7 | Inquiry | |
Proton-pump Inhibitor Lansoprazole Powder |
1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;AG 1749;Lansoprazole;A 65006;(±)-Lansoprazole;Prevacid;PP/K-10;Lanfast;Lanzor;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole;Ilsatec;Agopton;Lanproton;Lansopep;Lanston;Lanz;Lanzol 30;Lanzopral;Ogastro;Promp;Prosogan;Suprecid;Takepron;Ulpax;Zoton;Ketian;Lancid;Ogast;Lansophed;Lapraz;Lansox;Takepron OD;Tapepron;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole;Lansor;Lanzol;Lansofast;Propilan;Lanzole;Lanzopen;2-[[[4-(2,2,2-Trifluoroethoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole;Lanpro;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole;Lanzo;Cinfa;Davur;Alter;Lanso;(±)-Lansoprazol;Levant;RS-lansoprazole;Lasoprazole;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole;2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole;154727-72-7;909251-59-8 |
103577-45-3 | Inquiry |